Medicon Hellas S.A. - Asset Resilience Ratio
Medicon Hellas S.A. (MEDIC) has an Asset Resilience Ratio of 32.11% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read MEDIC current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2022)
This chart shows how Medicon Hellas S.A.'s Asset Resilience Ratio has changed over time. See what is Medicon Hellas S.A.'s book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Medicon Hellas S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Medicon Hellas S.A..
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €10.21 Million | 32.11% |
| Short-term Investments | €0.00 | 0% |
| Total Liquid Assets | €10.21 Million | 32.11% |
Asset Resilience Insights
- Very High Liquidity: Medicon Hellas S.A. maintains exceptional liquid asset reserves at 32.11% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Medicon Hellas S.A. Industry Peers by Asset Resilience Ratio
Compare Medicon Hellas S.A.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Lavipharm S.A
AT:LAVI |
Drug Manufacturers - Specialty & Generic | 0.00% |
Annual Asset Resilience Ratio for Medicon Hellas S.A. (2020–2022)
The table below shows the annual Asset Resilience Ratio data for Medicon Hellas S.A..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 32.11% | €10.21 Million ≈ $11.94 Million |
€31.81 Million ≈ $37.19 Million |
-1.11pp |
| 2021-12-31 | 33.21% | €10.36 Million ≈ $12.11 Million |
€31.19 Million ≈ $36.47 Million |
+8.03pp |
| 2020-12-31 | 25.18% | €7.20 Million ≈ $8.42 Million |
€28.61 Million ≈ $33.45 Million |
-- |
About Medicon Hellas S.A.
Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It al… Read more